Showing results (101-110 of 8,520) with videos related to

Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|July 26, 2019
Review article: diagnosis and management of intestinal failure-associated liver disease in adultsAshley Bond, Angelique Huijbers, Loris Pironi, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Population-based case-control study: chemoprotection of colorectal cancer with non-aspirin nonsteroidal anti-inflammatory drugs and other drugs for pain controlAntonio Rodríguez-Miguel, Luis A García-Rodríguez, Miguel Gil, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Review article: the incidence and risk factors for irritable bowel syndrome in population-based studiesFrancis Creed
Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2024
Steatotic liver disease-associated all-cause/cause-specific mortality in the United StatesDonghee Kim, Karn Wijarnpreecha, George Cholankeril, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2024
Diagnostic yield from symptomatic lower gastrointestinal endoscopy in the UK: A British Society of Gastroenterology analysis using data from the National Endoscopy DatabaseDavid Beaton, Linda Sharp, Liya Lu, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2013
Review article: vitamin D and inflammatory bowel diseasesV P Mouli, A N Ananthakrishnan
Alimentary Pharmacology & Therapeutics|August 1, 1989
Geographical differences of gastric ulcer healing rate in patients treated with ranitidine or placeboJ S Dixon, P R Worthington, J G Mills, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1989
A comparison of metoclopramide and trimebutine on small bowel motility in humansS Grandjouan, S Chaussade, D Couturier, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1989
Effects of the glucosidase inhibitor acarbose in patients with liver cirrhosisM C Zillikens, G R Swart, J W van den Berg, et al.
Pageof 852